# OnCo record da-aducanumab (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/da-aducanumab/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "da-aducanumab" ;
  schema:name "Aducanumab"@en ;
  schema:description "Aducanumab was an amyloid antibody whose US Alzheimer’s indication was later withdrawn. It is historical context, not a current option."@en ;
  schema:url <https://onco.cc/drugs/da-aducanumab/> ;
  schema:dateModified "2026-09-21"^^xsd:date ;
  schema:citation <https://www.fda.gov/drugs/accelerated-approval-program/withdrawn-non-malignant-hematological-neurological-and-other-disorder-indications-accelerated> ;
  onco:status "withdrawn" ;
  onco:tag "dementia-atlas" ;
  onco:modality "mAb" ;
  schema:alternateName "Aduhelm" ;
  onco:cancers <https://onco.cc/diagnoses/alzheimers-disease/> ;
  onco:companies <https://onco.cc/companies/da-biogen/> ;
  onco:trials <https://onco.cc/trials/da-trial-engage/> .